Cargando…

Impact of long-term glycemic variability on development of atrial fibrillation in type 2 diabetic patients

OBJECTIVE: It is well known that patients with type 2 diabetes mellitus (T2DM) have a high risk of atrial fibrillation (AF). The current study was designed to determine the relationship between long-term glycemic variability and incidence of new-onset AF in T2DM patients. METHODS: Between January 20...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Jun, Fan, Yu-Qi, Zhang, Jun-Feng, Wang, Chang-Qian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kare Publishing 2017
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282889/ https://www.ncbi.nlm.nih.gov/pubmed/29256876 http://dx.doi.org/10.14744/AnatolJCardiol.2017.7938

Ejemplares similares

Higher long-term visit-to-visit glycemic variability predicts new-onset atrial fibrillation in patients with diabetes mellitus
por: Hsu, Jung-Chi, et al.
Publicado: (2021)

Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus
por: Gu, Jun, et al.
Publicado: (2018)

Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation
por: Chan, Yi-Hsin, et al.
Publicado: (2020)

The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes
por: Jun, Ji Eun, et al.
Publicado: (2015)

Association of glycemic variability with left ventricular diastolic function in type 2 diabetes mellitus
por: Yokota, Shun, et al.
Publicado: (2019)

Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study
por: Cardoso, C. R. L., et al.
Publicado: (2018)

Asymmetric dimethylarginine and long-term adverse cardiovascular events in patients with type 2 diabetes: relation with the glycemic control
por: Hsu, Chiao-Po, et al.
Publicado: (2014)

Glycemic variability is associated with subclinical atherosclerosis in Chinese type 2 diabetic patients
por: Mo, Yifei, et al.
Publicado: (2013)

Glycemic variability and the risk of atrial fibrillation: a meta-analysis
por: Li, Wei, et al.
Publicado: (2023)

Type of atrial fibrillation and outcomes in patients without oral anticoagulants
por: Ren, Jiameng, et al.
Publicado: (2020)

Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes
por: Su, Gong, et al.
Publicado: (2011)

High variability in bodyweight is associated with an increased risk of atrial fibrillation in patients with type 2 diabetes mellitus: a nationwide cohort study
por: Lee, Hyun-Jung, et al.
Publicado: (2020)

Diabetes induces remodeling of the left atrial appendage independently of atrial fibrillation in a rodent model of type-2 diabetes
por: Yosefy, Or, et al.
Publicado: (2021)

Sex, age, type of diabetes and incidence of atrial fibrillation in patients with diabetes mellitus: a nationwide analysis
por: Bisson, Arnaud, et al.
Publicado: (2021)

Diabetes and atrial fibrillation in hospitalized patients in the United States
por: Kumar, Nilay, et al.
Publicado: (2021)

Prognostic significance of diabetes mellitus in patients with atrial fibrillation
por: Papazoglou, Andreas S., et al.
Publicado: (2021)

Glycemic variability in continuous glucose monitoring is inversely associated with baroreflex sensitivity in type 2 diabetes: a preliminary report
por: Matsutani, Daisuke, et al.
Publicado: (2018)

HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target
por: Ceriello, Antonio, et al.
Publicado: (2022)

Difference in left atrial appendage remodeling between diabetic and nondiabetic patients with atrial fibrillation
por: Yosefy, Chaim, et al.
Publicado: (2019)

J-curve relationship between long term glycemic control and mortality in diabetic patients with acute myocardial infarction undergoing percutaneous coronary intervention
por: Choi, Ik Jun, et al.
Publicado: (2021)

Mitral isthmus block is associated with favorable outcomes after reablation for long‐standing persistent atrial fibrillation
por: Wang, Xin‐hua, et al.
Publicado: (2020)

Chronic kidney disease and undiagnosed atrial fibrillation in individuals with diabetes
por: Heo, Nam Ju, et al.
Publicado: (2020)

Underweight is a major risk factor for atrial fibrillation in Asian people with type 2 diabetes mellitus
por: Hsu, Jung-Chi, et al.
Publicado: (2021)

The immediate trends in atrial electrical remodeling for paroxysmal atrial fibrillation across different modes of catheter ablation
por: Hou, Qian, et al.
Publicado: (2021)

Early and long-term outcomes and quality of life after concomitant mitral valve surgery, left atrial size reduction, and radiofrequency surgical ablation of atrial fibrillation
por: Joshibayev, Seitkhan, et al.
Publicado: (2016)

Age at Diagnosis of Atrial Fibrillation and Incident Dementia
por: Zhang, Wenya, et al.
Publicado: (2023)

Associations of hypoglycemia, glycemic variability and risk of cardiac arrhythmias in insulin-treated patients with type 2 diabetes: a prospective, observational study
por: Andersen, Andreas, et al.
Publicado: (2021)

The impact of weight loss related to risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium–glucose cotransporter 2 inhibitor
por: Chan, Yi-Hsin, et al.
Publicado: (2021)

Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in Taiwan
por: Chang, Chia-Yu, et al.
Publicado: (2017)

Thromboembolism, bleeding and vascular death in nonvalvular atrial fibrillation patients with type 2 diabetes receiving rivaroxaban or warfarin
por: Coleman, Craig I., et al.
Publicado: (2021)

Association of Sodium-Glucose Cotransporter-2 Inhibitors With Incident Atrial Fibrillation in Older Adults With Type 2 Diabetes
por: Zhuo, Min, et al.
Publicado: (2022)

A study of factors influencing long-term glycemic variability in patients with type 2 diabetes: a structural equation modeling approach
por: Gan, Yuqin, et al.
Publicado: (2023)

Comparison of high‐power short‐duration and low‐power long‐duration radiofrequency ablation for treating atrial fibrillation: Systematic review and meta‐analysis
por: Chen, Chao‐feng, et al.
Publicado: (2020)

Fluvastatin therapy could not decrease progression of paroxysmal atrial fibrillation in non-valvular disease patients
por: Tan, Qiang, et al.
Publicado: (2017)

Impact of glycemic control on the association of endothelial dysfunction and coronary artery disease in patients with type 2 diabetes mellitus
por: Chen, Shuai, et al.
Publicado: (2021)

Long-term Effect of Islet Transplantation on Glycemic Variability
por: Bertuzzi, Federico, et al.
Publicado: (2018)

Oral Anticoagulant Use and Long-Term Follow-Up Results in Patients with Non-valvular Atrial Fibrillation in Turkey AFTER-2 Study
por: Güzel, Tuncay, et al.
Publicado: (2022)

Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study
por: Grundvold, Irene, et al.
Publicado: (2015)

Atrial fibrillation and its arrhythmogenesis associated with insulin resistance
por: Chan, Yi-Hsin, et al.
Publicado: (2019)

Possible effects of glimepiride beyond glycemic control in patients with type 2 diabetes: a preliminary report
por: Nakamura, Ikuko, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hqv11mk7fbrvu4b78tofh7ht65